基于并行MCMC的色谱模型参数估计多模态辨识收敛性诊断
Clustering-based convergence diagnostic for multi-modal identification in parameter estimation of chromatography model with parallel MCMC
摘要:
由于模型与实验的不一致性,使得多模态模型的标定存在困难。应用贝叶斯推断和\textsc{mcmc}算法得到了模型参数在不确定性下的后验分布。然而,多模态导致并行\textsc{mcmc}采样链的收敛准则的困难。当多个采样链发展到不同模式时,常用的$\widehat{R}$诊断不能很好地工作。分区和层次聚类方法已被结合到传统的$\widehat{R}$诊断处理采样的目标分布是粗糙和多模态。结果表明,结合参数和孔隙扩散参数的分布是多模态的。因此,用于描述模型蛋白质溶菌酶对\textsc{sp} Sepharose \textsc{ff}固定相的离子交换效应的空间质量作用模型在某些实验条件下可能不完全可行,因为空间质量作用的模型不确定性将导致多模态。
英文摘要:
Uncertainties from experiments and models render multi-modal difficulties in model calibrations. Bayesian inference and \textsc{mcmc} algorithm have been applied to obtain posterior distributions of model parameters upon uncertainty. However, multi-modality leads to difficulty in convergence criterion of parallel \textsc{mcmc} sampling chains. The commonly applied $\widehat{R}$ diagnostic does not behave well when multiple sampling chains are evolving to different modes. Both partitional and hierarchical clustering methods has been combined to the traditional $\widehat{R}$ diagnostic to deal with sampling of target distributions that are rough and multi-modal. It is observed that the distributions of binding parameters and pore diffusion of particle parameters are multi-modal. Therefore, the steric mass-action model used to describe ion-exchange effects of the model protein, lysozyme, on the \textsc{sp} Sepharose \textsc{ff} stationary phase might not be fully capable in certain experimental conditions, as model uncertainty from steric mass-action would result in multi-modality.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。